TriNutra receives Thai FDA approval for black seed oil ingredient

TriNutra’s black seed oil has been clinically tested to support a balanced inflammatory response, deliver significant antioxidant activity, amongst other benefits

TriNutra has announced that its black seed oil, ThymoQuin, has been approved by the Thailand Food and Drug Administration (TFDA) as a novel food to be sold in dietary supplements in the region. The ingredient had demonstrated its quality and stability to comply with the ministry’s quality standards.

“We are incredibly proud to reveal this achievement in Thailand,” said Morris Zelkah, CEO of TriNutra. “The sales and awareness of black seed oil continue to grow, and with our exclusive Thailand distribution partner, Aumento Chemical, we can now offer our clinically studied, high quality, potent, and bioavailable black seed oil to Thai residents.”

The TFDA was established under the Ministry of Public Health to protect public health and consumer rights. It oversees the manufacturing, import, and distribution of regulated products to ensure they comply with strict safety and quality standards.  

“ThymoQuin offers the highest quality black seed oil with clinically validated health benefits,” said Watcharee Saponowong, managing director of Aumento Chemical. “We are happy to provide this powerful ingredient to our Thailand residents for improved health and wellbeing. We have the TFDA registration numbers and welcome customers to contact us for more information.” 

TriNutra’s black seed oil is naturally standardised to 3% thymoquinone with low free fatty acids (below 1.25%). This USP-grade, full-spectrum composition has been clinically tested to support a balanced inflammatory response, improve mitochondrial activity, including ATP production, and deliver significant antioxidant activity and antimicrobial effects. ThymoQuin is currently available in multiple continents and countries including, but not limited to North America, Europe, APAC.